PRF1 and neoplasm: hetIL-15 directly affects NK, CD8+ and CD4+ T cells within the tumor promoting their proliferation, survival and cytotoxic commitment, with high levels of IFN-γ production and upregulation of GzmA, GzmB and perforin.